Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy

Hematological Oncology

Volumn 25, Issue 1, 2007, Pages 11-15

  Hodgson, David C ^a,b   Pintilie, Melania ^a   Gitterman, Leah ^a   DeWitt, Beth ^a   Buckley, Carol Ann ^a   Ahmed, Sameera ^a   Smith, Katherine ^a   Schwartz, Amanda ^a   Tsang, Richard W ^a,b   Crump, Michael ^a,b   Wells, Woodrow ^a,b   Sun, Alexander ^a,b   Gospodarowicz, Mary K ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Chemotherapy; Fertility; Hodgkin lymphoma; Toxicity

Indexed keywords

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; HODGKIN DISEASE; HUMAN; MATERNAL AGE; MULTIPLE CYCLE TREATMENT; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; SEXUAL INTERCOURSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CASE-CONTROL STUDIES; DACARBAZINE; DOXORUBICIN; FEMALE; FERTILITY; HODGKIN DISEASE; HUMANS; PREGNANCY; PREGNANCY RATE; QUESTIONNAIRES; SURVIVORS; VINBLASTINE;

EID: 33947532554     PISSN: 02780232     EISSN: 10991069     Source Type: Journal    
DOI: 10.1002/hon.802     Document Type: Article

References (35)

1. Sutton PD, Mathews TJ. National vital statistics report. Trends in characteristics of births by State: United States, 1990, 1995, and 2000-2002. 2004; 52(19).
2. Sleebos JE. Low fertility rates in OECD countries:facts and policy responses. Paris: organisation for economic co-operation and development; 2003.
3. Bonadonna G, Santoro A, Viviani S, Lombardi C, Ragni G. Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens. Arch Toxicol Suppl 1984; 7: 140-145.
4. Behringer K, Breuer K, Reineke T, et al. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. J Clin Oncol 2005; 23(30): 7555-7564.
5. Brusamolino E, Lunghi F, Orlandi E, et al. Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. Haematologica 2000; 85(10): 1032-1039.
6. Juul S, Karmaus W, Olsen J. Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group. Hum Reprod 1999; 14(5): 1250-1254.
7. Olsen J, Juul S, Basso O. Measuring time to pregnancy. Methodological issues to consider. Hum Reprod 1998; 13(7): 1751-1753.
8. Bolumar F, Olsen J, Boldsen J. Smoking reduces fecundity: a European multicenter study on infertility and subfecundity. The European study group on infertility and subfecundity. Am J Epidemiol 1996; 143(6): 578-587.
9. Curtis KM, Savitz DA, Arbuckle TE. Effects of cigarette smoking, caffeine consumption, and alcohol intake on fecundability. Am J Epidemiol 1997; 146(1): 32-41.
10. Hassan MA, Killick SR. Is previous use of hormonal contraception associated with a detrimental effect on subsequent fecundity? Hum Reprod 2004; 19(2): 344-351.
11. Buck GM, Vena JE, Schisterman EF, et al. Parental consumption of contaminated sport fish from Lake Ontario and predicted fecundability. Epidemiology 2000; 11(4): 388-393.
12. Sallmen M, Lindbohm ML, Anttila A, Taskinen H, Hemminki K. Time to pregnancy among the wives of men occupationally exposed to lead. Epidemiology 2000; 11(2): 141-147.
13. Curtis KM, Savitz DA, Weinberg CR, Arbuckle TE. The effect of pesticide exposure on time to pregnancy. Epidemiology 1999; 10(2): 112-117.
14. Joffe M, Key J, Best N, Keiding N, Scheike T, Jensen TK. Studying time to pregnancy by use of a retrospective design. Am J Epidemiol 2005; 162(2): 115-124.
15. Weinberg CR, Baird DD, Wilcox AJ. Sources of bias in studies of time to pregnancy. Stat Med 1994; 13(5-7): 671-681.
16. Weinberg CR, Baird DD, Rowland AS. Pitfalls inherent in retrospective time-to-event studies: the example of time to pregnancy. Stat Med 1993; 12(9): 867-879.
17. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin's disease. Ann Oncol 2002; 13(Suppl. 1): 138-147.
18. Chiarelli AM, Marrett LD, Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario, Canada. Am J Epidemiol 1999; 150(3): 245-254.
19. Kreuser ED, Xiros N, Hetzel WD, Heimpel H. Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 1987; 113(3): 260-266.
20. Howell S, Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 1998; 27(4): 927-943.
21. Franchi-Rezgui P, Rousselot P, Espie M, et al. Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 2003; 4(2): 116-120.
22. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983; 52(6): 988-993.
23. Bokemeyer C, Schmoll HJ, van Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 1994; 68(3): 105-110.
24. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 1985; 21(5): 601-605.
25. Anselmo AP, Cartoni C, Bellantuono P, Maurizi-Enrici R, Aboulkair N, Ermini M. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/ MOPP. Haematologica 1990; 75(2): 155-158.
26. Heikens J, Behrendt H, Adriaanse R, Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 1996; 78(9): 2020-2024.
27. Dhabhar BN, Malhotra H, Joseph R, et al. Gonadal function in prepubertal boys following treatment for Hodgkin's disease. Am J Pediatr Hematol Oncol 1993; 15(3): 306-310.
28. Andre M, Brice P, Cazals D, et al. Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin's disease (stage I, II and IIIA). Hematol Cell Ther 1997; 39(2): 59-65.
29. Tal R, Botchan A, Hauser R, Yogev L, Paz G, Yavetz H. Follow-up of sperm concentration and mortility in patients with lymphoma. Human Reproduction 2000; 15(9): 1985-1988.
30. Kulkarni SS, Sastry PS, Saikia TK, Parikh PM, Gopal R, Advani SH. Gonadal function following ABVD therapy for Hodgkin's disease. Am J Clin Oncol 1997; 20(4): 354-357.
31. Axmon A, Rylander L, Albin M, Hagmar L. Factors affecting time to pregnancy. Hum Reprod 2006.
32. Juul S, Keiding N, Tvede M. Retrospectively sampled time-to-pregnancy data may make age-decreasing fecundity look increasing. European Infertility and Subfecundity Study Group. Epidemiology 2000; 11(6): 717-719.
33. Olsen J. Cigarette smoking, tea and coffee drinking, and subfecundity. Am J Epidemiol 1991; 133(7): 734-739.
34. Jensen TK, Hjollund NH, Henriksen TB, et al. Does moderate alcohol consumption affect fertility? Follow up study among couples planning first pregnancy. Bmj 1998; 317(7157): 505-510.
35. Bolumar F, Olsen J, Rebagliato M, Saez-Lloret I, Bisanti L. Body mass index and delayed conception: a European multicenter study on infertility and subfecundity. Am J Epidemiol 2000; 151(11): 1072-1079.